Name | ceftezole sodium |
Synonyms | Alomen Falomesin CEFTEZOLE SODIUM CDFTEZOLE SUDIUM ceftezole sodium 5-Thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic sodium 8-oxo-7-((1h-tetrazol-1-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicaci ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-,monosodiumsalt,(6r-t sodium (6S,7R)-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 8-oxo-7-[(1h-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt (6R)-7α-[[(1H-Tetrazol-1-yl)acetyl]amino]-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt |
CAS | 41136-22-5 |
EINECS | 1592732-453-0 |
InChI | InChI=1/C13H12N8O4S3.Na/c22-7(1-20-4-14-18-19-20)16-8-10(23)21-9(12(24)25)6(2-26-11(8)21)3-27-13-17-15-5-28-13;/h4-5,8,11H,1-3H2,(H,16,22)(H,24,25);/q;+1/p-1/t8-,11+;/m1./s1 |
Molecular Formula | C13H11N8NaO4S3 |
Molar Mass | 462.46 |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
This product is (6R,7R)-3-[[(1,3, 4-thiadiazol-2-yl) thio] methyl]-7-[(1H-tetrazol-1-yl) acetylamino]-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid sodium salt 3, calculated as anhydrous, containing ceftezole (C13H12N804S3) shall not be less than 90.0%.
take this product, precision weighing, adding water to dissolve and quantitatively dilute to make about 0 in each lml. lg of the solution, determined according to law (General rule 0621), specific rotation -5 ° to -9%°.
take this product, precision weighing, add water to dissolve and quantitatively dilute to make a solution containing about 16ug per lml, according to UV-visible spectrophotometry (General 0401), the absorbance was measured at a wavelength of 272mn, and the absorption coefficient was 270 to 300.
take this product, add water to make a solution containing O.lg per lml, and determine it according to law (General 0631). The pH value should be 4.5~6.5.
take 5 parts of this product, each 0.6g, respectively, after adding water 5ml to dissolve, the solution should be clear and colorless; If it is turbid, compare with No. 1 turbidity standard solution (General rule 0902 first method), shall not be more concentrated; If the color is developed, it shall not be deeper in comparison with the yellow or yellow-green standard colorimetric solution No. 6 (General Principles 0901 first method).
take an appropriate amount of this product, add water to dissolve and dilute to make a solution containing about 1 mg per 1 ml, as a test solution; Take an appropriate amount of precision, A solution containing about 10ug per 1 ml was prepared as a control solution by quantitative dilution with water. The appropriate amount of the control solution was accurately taken, and the solution containing about 0.5ug per 1 ml was prepared by quantitative dilution with water as the sensitivity solution. According to the chromatographic conditions under the content determination item, take the sensitivity solution 20 u1, inject the human liquid chromatograph, record the chromatogram, and the signal to noise ratio of the main component peak height should be greater than 10. Then 20 u1 of the test solution and the control solution are accurately weighed and injected into the human liquid chromatograph respectively, and the chromatogram is recorded to 2.5 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than the area of the main peak of the control solution (1.0% ) , and the sum of each impurity peak area shall not be greater than 1.5 times (1.5%) of the area of the main peak of the control solution. No. The peaks in the chromatogram of the test solution which are smaller than the main peak area of the sensitivity solution are ignored.
measured by size exclusion chromatography (General 0514).
with dextran gel G-10(40 ~ 120um) as the filler, the inner diameter of the glass column is 1.0~1.4, the length of the column is 30 ~ 40cm, mobile phase A was 0.075mol/L phosphate buffer solution [0.075mol/L disodium hydrogen phosphate solution -0.075mol/L sodium dihydrogen phosphate solution (61:39)], the flow rate was 1.5ml per minute and the detection wavelength was 254nm. Take 0.4-200u1 of 2000 mg/ml Blue dextran 100 solution and inject it into human Liquid Chromatograph. Use mobile phase A and B as mobile phase respectively to record chromatogram. The number of theoretical plates shall not be less than 2000 based on the Blue dextran 300 peak, and the tailing factor shall be less than 2.0, the ratio of the retention times of the Blue dextran 2000 peak in the two mobile phase systems should be between 0.93 and 1.07, the ratio of the retention time of the main peak of the control solution to the polymer peak in the test solution and the Blue dextran 2000 peak in the corresponding chromatographic system should be between 0.93 and 1.07, weigh about 0.2g of this product, in A 10ml measuring flask, dissolve in 0.4mg/ml 2000 Blue dextran solution and dilute to the scale, shake well, inject 100~200u1 into human liquid chromatograph, and measure with mobile phase A, the ratio of the peak height of the high polymer to the valley height between the monomer and the high polymer should be greater than 2.0. In addition, the mobile phase B is used as the mobile phase, and 100~200 u1 of the control solution is accurately measured, and the sample is continuously injected for 5 times, the relative standard deviation of peak area should not be more than 5.0%.
an appropriate amount of ceftezole reference substance was accurately weighed, dissolved with water and quantitatively diluted to prepare a solution containing about 25ug per 1 ml. Determination of this product is about 0.3g, precision weighing, 10ml measuring flask, add water to dissolve and dilute to the scale, shake. Immediately, 100-200ul is injected into the liquid chromatograph accurately, mobile phase A is used as the mobile phase for measurement, and the chromatogram is recorded. In addition, 100-200u1 of the control solution was injected into the liquid chromatograph in a precise amount, the mobile phase B was used as the mobile phase for measurement, and the chromatogram was recorded. The amount of ceftezole polymer shall not exceed 0.05% calculated by the peak area of ceftezole according to the external standard method.
take this product, according to the determination of moisture (General 0832 first method 1), the water content shall not exceed 5.0%.
take 5 parts of this product, each 4.0g, with particle inspection water dissolution, inspection according to law (General 0904), should comply with the provisions. (For aseptic dispensing)
Take 3 parts of this product, and use the particle inspection water to make a solution containing 60mg per 1 ml, and check according to law (General rule 0903), no more than 6000 particles of 10um and more than 10um in each lg sample, and no more than 600 particles of 25um and more than 25um. (For aseptic dispensing)
take this product, check according to law (General rule 1143 ), the amount of endotoxin per 1 mg ceftezole should be less than 0.075EU. (For injection)
take this product, dissolve and dilute with sterile water, after membrane filtration treatment, inspection according to law (General rule 1101), should comply with the provisions. (For aseptic dispensing)
measured by high performance liquid chromatography (General 0512).
silica gel bonded with eighteen alkyl silane was used as filler; Citric acid solution (3g of citric acid was taken, dissolved in water and diluted to 900ml)-acetonitrile (90:10) was used as mobile phase; the detection wavelength was 254nm. Take about 25mg of ceftezole reference, put it in a 25ml measuring flask, add 0.1 mol/L sodium hydroxide solution (1 ml) was dissolved and placed for 1 min. lmol/L hydrochloric acid solution (lml) was neutralized, diluted with water to scale, to obtain a mixed solution containing about ceftezole lmg and its degradation impurities per 1 mL (wherein the amounts of impurities at relative retention times of about 0.8 and 1.7 are about 0.5% and 2% ), take 20u1 injection human liquid chromatograph, record chromatogram, ceftezole peak retention time is about 13 minutes, ceftezole peak and its relative retention time is about 0.8, the separation degree between impurity peaks should be greater than 4.0.
take an appropriate amount of this product, accurately weigh it, add water to dissolve it and quantitatively dilute it to make a solution containing about 0.2mg per lml, as a test solution, and take 20ul of the precision quantity to inject human liquid chromatograph, record the chromatogram; Take the appropriate amount of ceftezole reference, and determine with the same method. The content of C13H12N804S3 in the test sample was calculated by the peak area according to the external standard method.
B-lactam antibiotics, cephalosporins.
sealed and stored in a cool dark dry place.
This product is ceftezole sodium sterile powder. Calculated as anhydrous, containing ceftezole (C13H12N804S3) shall not be less than 90.0%; Calculated as the average loading, containing ceftezole (C13H12N804S3) shall be 90.0% ~ 110.0% of the label amount.
This product is white to light yellow powder or crystalline powder; Odorless, with hygroscopicity.
take this product, according to ceftezole sodium under the identification test, showed the same results.
The content under the item of loading amount difference was taken and measured according to the method under the item of ceftezole sodium.
Same as ceftezole sodium.
calculated by C13H12N804S3 (1)0.25g (2)0.5g(3)0.75g (4)1.0g (5)1.5g (6)2.Og (7)4.0g
sealed and stored in a cool dark dry place.